Thursday, November 30, 2023
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba’s Soberana Plus Vaccine Candidate is Safe

Havana, May 10 (Prensa Latina) The Soberana Plus vaccine candidate developed in Cuba and administered to people suffering from Covid-19 was classified as safe.

Speaking on Cuban television, the main researcher in the clinical trials on Soberana Plus, Arturo Chang, explained that the study was excellent, and they wanted to demonstrate its safety in several age groups.

Soberana Plus can raise the antibodies of these people, said Chang.

There is scientific evidence that humans can be reinfected with the SARS-CoV-2 coronavirus, which causes the disease, and Cuba is working to protect convalescents as well, the expert stressed.

Soberana Plus is designed for people already vaccinated and one dose is enough to increase their protection, Chang explained.

He noted that the placebo is present in phase II of the Soberana Plus clinical trial as part of the good practices that must be complied with from the scientific point of view, such as the demonstration of the hypothesis that the vaccine candidate is immunogenic.

The scientist cleared doubts about the link between the vaccine and hypertension.

He emphasized that the vaccine candidate does not increase blood pressure; the people who made reference to this point were already hypertensive, they just did not know it.

After injecting Soberana Plus, self-care, physical distancing and correct use of the face masks must be maintained, Chang reminded, and said that the level of efficacy of the vaccine candidate has yet to be evaluated.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.